Corrigendum to "Bortezomib-resistant multiple myeloma patient-derived xenograft is sensitive to anti-CD47 therapy" [Leuk. Res. 122 (2022) 106949]. (May 2023) - Yue, Yanhua; Cao, Yang; Wang, Fei; Zhang, Naidong; Qi, Ziwei; Mao, Xunyuan; Guo, Shuxin; Li, Feng; Guo, Yanting; Lin, Yan; Dong, Weimin; Huang, Yuhui; et al.